A brief account of the major developments of palladium-catalyzed cross-coupling during the last two decades is highlighted chronologically, with an emphasis on the personal experiences of the corresponding author. Important contributions from both academia and industry, which have been vital to the accelerated growth of this area, are presented. The developments of new classes of ligands and the switch from in situ to preformed catalysts tailored to address the challenges in cross-coupling are reviewed, reflecting an evolution in continued growth.
No takes yet. Share an insight, caveat, or question.
Gildner et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: